Navigation Links
Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
Date:11/19/2007

us in human colon, gastric, and pancreatic tumor xenograft models in vivo and has been found to be well tolerated in repeat dose primate toxicology studies.

About GI Cancers

Adenocarcinomas are malignant tumors of the epithelial cells that line glands or viscera. They typically spread by way of the circulatory or lymphatic systems and are poorly treated after metastatic spread. More than 90 percent of colon, stomach and pancreatic tumor specimens express the RAV12 defined antigen, RAAG12. Adenocarcinomas arising elsewhere, such as breast, endometrial, ovarian, lung and prostate, display the antigen to varying degrees.

About Raven

Raven biotechnologies, inc. (http://www.ravenbio.com) is a privately held biotechnology company focused on the development of monoclonal antibody therapeutics for treating cancer. Raven's lead product candidate, RAV12, targets adenocarcinomas and is in clinical development for the treatment of gastrointestinal and other cancers. Raven's discovery process simultaneously identifies cell-surface drug targets and the antibody therapeutics to regulate them. Our focus on biological function allows us to rapidly identify novel target antigens and therapeutic candidates in their native configuration in the intact cell membrane. Our integrated approach is based on proprietary methods for optimizing the production of MAbs targeting cell-surface proteins, including the use of human tissue-specific progenitor and tumor stem cell lines developed at Raven.

To date Raven has identified multiple candidate therapeutic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer.


'/>"/>
SOURCE Raven biotechnologies, inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... /CNW/ - The Taskforce representing Canada,s ... hard work that the Minister and Health Canada have put ... recognizes the needs of the thalidomide survivors, and more than ... tax free, with annual adjustments for inflation. Certain ... of $100,000 based on the severity of their disability, tax ...
(Date:5/22/2015)... , May 22, 2015  BioLife Solutions, Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and cryopreservation ... for cells and tissues ("BioLife" or the "Company"), announced that ... MicroCap Conference. The Company is scheduled to ... May 27, 2015 at the Grand Hyatt Hotel in ...
(Date:5/22/2015)... ROCKVILLE, Md. , May 22, 2015  RegeneRx ... focused on tissue protection, repair and regeneration, today announced ... RegeneRx, is scheduled to present a corporate overview at ... will present at the SeeThruEquity 4 th Annual ... New York City at 11:00 am ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3
... from EAP in 2007, RICHMOND, Va., Jan. ... follow-on biologics and biopharmaceuticals, today,provided an update on ... the treatment of Amyotrophic Lateral Sclerosis (ALS). Since ... physicians and approximately 70 subjects,have been enrolled into ...
... Kind in US, Finds Allergy Immunotherapy ... Beneficial Even When Treatment Not Completed, MOSS ... health economics and outcomes research, today announced,findings of a ... benefits to children and significantly reduces health,care costs, even ...
Cached Medicine Technology:Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis 2Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis 3Study Says Allergy Shots Help Children, Reduce Health Care Costs 2Study Says Allergy Shots Help Children, Reduce Health Care Costs 3
(Date:5/25/2015)... May 26, 2015 According to the National ... retinitis pigmentosa , a degenerative eye disease. The National Library ... has paroxysmal kinesigenic dyskinesia , a rare disorder that ... Joseph K. Chan , these two diseases are more than ... to walk in his shoes with his new autobiography “ ...
(Date:5/25/2015)... 26, 2015 The National ... Dr. Heather Stanley-Christian as a 2015-2016 inductee ... She is recognized with this prestigious distinction for ... networking organization exclusively for professional women, boasting more ... chapters. , "I'm pleased to welcome Heather into ...
(Date:5/25/2015)... May 25, 2015 World Patent Marketing, ... announces the Hidee-Hose, an undergarment patent that allays women’s ... Global Women's Hosiery industry forecasts the market to reach ... and Creative Director of World Patent Marketing , ... steering ahead and is expected to maintain its lead. ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 Stanley ... awards for design of the wastewater treatment ... Iowa.    The project received a National Recognition Award from the ... Award from ACEC – Iowa. Competitions held by ... , The $50.2 million expansion is Iowa City’s largest ...
(Date:5/25/2015)... Henderson, NV (PRWEB) May 25, 2015 ... this year, the radical science-based human wellness company ... one-day workshop event from their world-class series titled, “Consciousness ... be held on June 13, 2015 at the routinely ... pm EST. The event will be made available to ...
Breaking Medicine News(10 mins):Health News:Joseph K. Chan Finds Faith from Disability in New Autobiography 2Health News:NAPW Inducts Dr. Heather Stanley-Christian, Systems Chair/Maternal Fetal Medicine at Stroger Hospital, into Its VIP Professional Woman of the Year Circle 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 3Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 2Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 3Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 2Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 3
... have found important new relationships between obesity, sleep-disordered ... children. "The intricate interdependencies between BMI, ... of particular importance in children, as their brains ... Spruyt, PhD, assistant professor in the Department of ...
... have identified high levels of a number of genes in ... than other rodents and demonstrate resistance to age-related diseases. ... data of the naked mole-rat - a rodent that lives ... - to understand its longevity and resistance to disease. ...
... partner danced a lively rumba to Spandau Ballet,s 1980,s hit, "True," ... in the legal commentator,s brain than worry over a possible wardrobe ... hard at work doing what they apparently had been built to ... a pas de deux that had the dancers functioning together (for ...
... News) --,A new British study finds that commercial ... than primary care-based programs led by specially trained ... loss among obese and overweight women and men ... weeks (Weight Watchers, Slimming World, Rosemary Conley) or ...
... 3 (HealthDay News) -- Smokers are more likely to kick ... brain that processes emotions was damaged by the stroke, researchers ... to stop smoking before they had a stroke were much ... hadn,t thought about quitting. These findings may lead to ...
... HealthDay Reporter , THURSDAY, Nov. 3 (HealthDay News) ... risk for cancer, just as the time they spend exercising ... colon and breast cancer we can now say there is ... developing those two major cancers," said Christine Friedenreich, a ...
Cached Medicine News:Health News:Body weight, sleep-disordered breathing and cognition linked in children 2Health News:Scientists identify genes that may signal long life in naked mole-rats 2Health News:It takes two: Brains come wired for cooperation, neuroscientist asserts 2Health News:Weighing Weight-Loss Programs 2Health News:Some Smokers More Likely to Quit After Stroke Than Others 2Health News:Too Much Sitting Raises Odds for Cancer: Study 2Health News:Too Much Sitting Raises Odds for Cancer: Study 3Health News:Too Much Sitting Raises Odds for Cancer: Study 4
The Horizontal-Vertical (H/V) lumbar valve system is the only differential pressure valve for lumbo-peritoneal shunting, which addresses orthostatic overdrainage....
26 cm - 10 1/4, 140 mm - 5 1/2, bayonet-shaped, flexible, 90 angle, 4 mm...
Toothed pituitary rongeur. Straight....
Micro pituitary style scissors, alligator action, semi-malleable shaft. Curved right....
Medicine Products: